Uncategorized Archives - QualityStocks

FridayJun 26, 2026 11:47 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) MyndRenew(TM) Earns TruShield Certification

BioAdaptives (OTC: BDPT) announced that MyndRenew(TM), the nighttime component of its MyndSystem(TM) cognitive health platform, has received TruShield Certified status, confirming compliance with anti-doping standards established by the World Anti-Doping Agency and the UFC. Combined with the previously certified MyndMed(TM) daytime formula, the company said MyndSystem(TM) is now a fully WADA-compliant 24/7 cognitive performance and recovery system for professional athletes. The company said the certification strengthens its position in the sports nutrition market by supporting potential adoption among professional athletes while also targeting executives and active seniors. BioAdaptives said the milestone could enhance commercialization opportunities, strategic partnerships and broader market adoption as it expands the MyndSystem(TM) platform. To view the full press release, visit https://ibn.fm/LiDRP About BioAdaptives, Inc. BioAdaptives,…

MondayJun 22, 2026 11:15 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Targets a $393 Billion Heart Disease Problem with Epigenetics and AI

For cardiovascular conditions, annual health care costs are forecasted to increase from $393 billion in 2020 to $1.4 trillion by 2050, almost quadrupling in size. What makes Cardio Diagnostics' approach distinct, and what gives the company a defensible clinical position, is its ability to detect coronary heart disease earlier and with high sensitivity. The company's recent commercial and regulatory milestones give additional shape to the investment thesis. Heart disease has held the grim distinction of being the leading cause of death in the United States for decades, and despite advances in medicine, the problem is getting worse, not better. According…

TuesdayJun 16, 2026 11:49 am

QualityStocksNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Acquires Strategic Stake in AnorTech

Greenland Mines (NASDAQ: GRML) has entered into a strategic share exchange agreement with AnorTech Inc. (TSX.V: ANOR) (OTCQB: ANORF), acquiring an initial 9.9% equity interest in the Greenland-focused technology and resource development company, with an option to increase its ownership to as much as 19.9% within six months. The company said the investment supports its North Atlantic Critical Metals Corridor strategy and provides exposure to AnorTech's sustainable alumina, high-purity alumina, CO2-free cement and industrial materials technologies derived from its Gronne Bjerg anorthosite project in Greenland. Greenland Mines said the transaction expands its reach beyond upstream resource development into the midstream processing segment of the critical materials value chain. AnorTech is advancing…

FridayJun 05, 2026 1:27 pm

QualityStocksNewsBreaks – Pinterest Inc. (NYSE: PINS) Gains Attention Following Report on $4 Billion AWS AI Investment Initiative

Pinterest (NYSE: PINS) attracted investor attention following a Benzinga report by Shanthi Rexaline highlighting the company's plans to invest approximately $4 billion over several years in a strategic partnership with Amazon Web Services ("AWS"). According to the report, the initiative is designed to strengthen Pinterest's artificial intelligence capabilities, enhance content personalization and improve advertising performance across its platform. The investment reflects Pinterest's broader effort to leverage advanced AI technologies to drive user engagement and support long-term revenue growth. As reported by Rexaline, the partnership is expected to provide Pinterest with expanded cloud infrastructure and access to advanced AI tools that can help optimize recommendations, search functionality and advertising solutions. The move underscores the growing…

ThursdayJun 04, 2026 11:19 am

QualityStocksNewsBreaks – BOXABL and FG Merger II (NASDAQ: FGMC) Set June 9 Vote on Proposed Business Combination

BOXABL announced that FGMC stockholders will vote June 9, 2026, on the proposed business combination that would take BOXABL public. FGMC is encouraging stockholders to vote in favor of the transaction and noted that public stockholders who do not redeem their shares will automatically become BOXABL stockholders upon closing. Following completion of the merger, FGMC is expected to be renamed BOXABL, Inc. and re-list on Nasdaq under the ticker symbol "BXBL." The deadline for public stockholders to exercise redemption rights is June 5, 2026, at 5 p.m. ET. To view the full press release, visit https://ibn.fm/7HtW9 About BOXABL BOXABL is transforming the housing market with its modular building systems designed to deliver affordable, high-quality homes at unprecedented speed. Founded…

ThursdayMay 28, 2026 10:11 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Nano to Present Deciparticle(TM) Nanomedicine Platform at BIO International Convention 2026

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Nano announced that Chief Executive Officer Vuong Trieu will present the Deciparticle(TM) nanomedicine platform at the BIO International Convention 2026 in San Diego, highlighting the development of ultra-small nanomedicine formulations designed to enable intravenous administration of highly water-insoluble therapeutics. The Deciparticle(TM) platform utilizes proprietary amphiphilic polymer systems capable of forming sub-20 nanometer particles for oncology and other therapeutic applications. The companies plan to showcase development progress across multiple Deciparticle(TM) programs, including Sapu006, a polysorbate-free intravenous docetaxel formulation moving into Phase 1b clinical evaluation, and Sapu003, an intravenous everolimus nanomedicine program currently in a global Phase 1b clinical trial. The presentation will also highlight the integration…

WednesdayMay 20, 2026 10:40 am

QualityStocksNewsBreaks – Ideal Power Inc. (NASDAQ: IPWR) Secures $30 Million Financing to Accelerate B-TRAN Commercialization

Ideal Power (NASDAQ: IPWR) announced a definitive agreement with institutional investors for a $30 million registered direct offering priced at the market under Nasdaq rules, with proceeds expected to support commercialization of its B-TRAN(R) bidirectional semiconductor power switch, including customer design-ins, custom development programs and initial production ramp efforts with strategic partners. Titan Partners, a division of American Capital Partners, is acting as sole placement agent for the financing, which the company said strengthens its balance sheet as it pursues growing opportunities tied to power efficiency demand across data center and industrial markets. To view the full press release, visit…

FridayMay 15, 2026 10:20 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports First-Quarter Results, Highlights Progress Across Biotech Platform

Oncotelic Therapeutics (OTCQB: OTLC) reported first-quarter 2026 financial results and a corporate update highlighting continued advancement across its oncology, AI-enabled drug development and advanced drug delivery initiatives, including progress within its Sapu Nano joint venture and nose-to-brain CNS delivery platform. The company also said it maintained the previously established approximately $388 million fair value of its 45% ownership interest in GMP Biotechnology as of March 31, 2026, while continuing to pursue capital-efficient growth across its diversified biotechnology platform. To view the full press release, visit https://ibn.fm/DTVsF About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the…

MondayMay 11, 2026 1:40 pm

QualityStocksNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF), through subsidiary GlucaPharm Inc., is advancing GEP-44, a patented triple agonist peptide targeting GLP-1 and peptide YY receptors as the global obesity and metabolic disease market continues to expand. The company is pursuing a differentiated approach focused on improved efficacy, tolerability and delivery flexibility in a therapeutic category that has become one of the most commercially significant in modern healthcare, with long-term market projections exceeding $200 billion. SureNano is part of an increasingly competitive GLP-1 landscape led by Eli Lilly and Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Amgen…

MondayApr 13, 2026 10:05 am

QualityStocksNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Featured in NetworkNewsWire Editorial on Global Energy Supply Pressures

Greenland Energy (NASDAQ: GLND) announced its placement in an editorial published by NetworkNewsWire, highlighting how rising geopolitical tensions and disruptions to critical shipping routes such as the Strait of Hormuz are underscoring ongoing vulnerabilities in global energy security. The editorial emphasizes growing investor focus on companies advancing resource development in politically stable regions, positioning Greenland Energy as a key player through its exploration efforts in the Jameson Land Basin as part of broader efforts to strengthen Western energy independence. To view the full press release, visit: https://ibn.fm/KCtbR About Greenland Energy Company Greenland Energy Company (NASDAQ: GLND) is an energy exploration…

Site Search

Company Search

Category: Uncategorized